Profile data is unavailable for this security.
About the company
GUANGXI WUZHOU ZHONGHENG GROUP CO., LTD is a China-based company, principally engaged in the manufacture of pharmaceuticals and food production. The Company's pharmaceuticals include cardiovascular drugs, medicine for bruises, gynecology medication and other general drugs. The Company also provides Chinese herbal jelly products, Chinese herbal beverages and others. The Company is also engaged in the development of real estate, including the development and sales of commercial housings and stores. The Company mainly conducts its businesses within domestic market and to overseas markets.
- Revenue in CNY (TTM)3.23bn
- Net income in CNY156.14m
- Incorporated1993
- Employees2.89k
- LocationGuangxi Wuzhou Zhongheng Group Co LtdNo. 1Industrial Avenue, Industrial ParkWUZHOU 543000ChinaCHN
- Phone+86 7 743939022
- Fax+86 7 743939053
- Websitehttps://www.wz-zhongheng.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Lushang Freda Pharmaceutical Co Ltd | 4.20bn | 233.09m | 8.02bn | 3.65k | 34.41 | 1.97 | -- | 1.91 | 0.2293 | 0.2293 | 4.13 | 4.01 | 0.4446 | 0.8832 | 7.75 | 1,149,606.00 | 3.02 | 0.6992 | 5.84 | 5.12 | 48.44 | 20.23 | 6.79 | 3.45 | 2.67 | -- | 0.1251 | 40.33 | -64.65 | -12.29 | 567.44 | 13.36 | 44.40 | 14.87 |
| Shenzhen Lifotronic Technology Co Ltd | 1.17bn | 347.69m | 8.25bn | 1.48k | 23.73 | 4.32 | -- | 7.03 | 0.8120 | 0.8120 | 2.75 | 4.46 | 0.5409 | 2.32 | 7.90 | 792,478.60 | 15.97 | 13.82 | 19.66 | 16.33 | 65.70 | 61.01 | 29.52 | 26.10 | 3.51 | -- | 0.1004 | 41.51 | 16.55 | 28.78 | 30.66 | 32.27 | -7.91 | -- |
| Vcanbio Cell & Gene Engineering Corp Ltd | 1.61bn | 109.23m | 8.33bn | 2.21k | 76.26 | 2.26 | -- | 5.17 | 0.2334 | 0.2334 | 3.44 | 7.88 | 0.3034 | 2.01 | 2.86 | 728,818.10 | 1.97 | 1.13 | 2.79 | 1.61 | 67.97 | 67.76 | 6.51 | 3.84 | 1.52 | 6.93 | 0.0284 | 0.00 | 2.24 | 3.78 | -5.78 | 12.43 | -7.11 | -- |
| Guangxi Wuzhou Zhongheng Group Co Ltd | 3.23bn | 156.14m | 8.42bn | 2.89k | 53.72 | 1.28 | -- | 2.61 | 0.0454 | 0.0454 | 0.9413 | 1.91 | 0.2766 | 1.96 | 3.41 | 1,120,149.00 | 0.9542 | 2.26 | 1.51 | 3.38 | 53.66 | 72.05 | 3.45 | 7.27 | 2.38 | -- | 0.1795 | 45.67 | 14.10 | -1.26 | 6.69 | -32.76 | -4.56 | -30.12 |
| Wuhan Keqian Biology Co Ltd | 989.49m | 347.63m | 8.47bn | 923.00 | 24.53 | 2.17 | -- | 8.56 | 0.7408 | 0.7408 | 2.10 | 8.37 | 0.213 | 1.93 | 3.03 | 1,072,036.00 | 7.47 | 13.29 | 8.81 | 15.49 | 68.82 | 76.49 | 35.09 | 45.71 | 3.65 | -- | 0.0508 | 24.76 | 6.27 | 7.67 | -3.32 | 0.3556 | 27.17 | -- |
| Jianmin Pharmaceutical Group Co Ltd | 4.17bn | 521.42m | 8.70bn | 2.50k | 16.63 | 3.69 | -- | 2.09 | 3.41 | 3.41 | 27.26 | 15.35 | 1.04 | 5.81 | 4.34 | 1,669,960.00 | 13.09 | 10.87 | 23.66 | 19.11 | 43.70 | 43.04 | 12.56 | 9.32 | 1.26 | -- | 0.1891 | 37.15 | 15.72 | 14.28 | 27.78 | 45.05 | 8.77 | 43.10 |
| North China Pharmaceutical Co Ltd | 10.02bn | 17.62m | 8.89bn | 10.16k | 504.38 | 1.67 | -- | 0.8872 | 0.0103 | 0.0103 | 5.84 | 3.11 | 0.4693 | 2.71 | 4.31 | 986,082.90 | 0.3543 | -0.2978 | 0.8122 | -0.7042 | 30.26 | 35.73 | 0.755 | -0.5985 | 0.5425 | 1.43 | 0.6473 | -- | -3.62 | 1.89 | 100.71 | -49.62 | 4.22 | -19.73 |
Data as of Apr 18 2024. Currency figures normalised to Guangxi Wuzhou Zhongheng Group Co Ltd's reporting currency: Chinese Yuan Renminbi CNY
5.34%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| China Investment Corp. (Investment Management)as of 08 Mar 2024 | 49.78m | 1.45% |
| China Southern Asset Management Co., Ltd.as of 08 Mar 2024 | 25.30m | 0.74% |
| Da Cheng Fund Management Co., Ltd.as of 08 Mar 2024 | 25.30m | 0.74% |
| GF Fund Management Co., Ltd.as of 08 Mar 2024 | 25.28m | 0.74% |
| Yinhua Fund Management Co., Ltd.as of 08 Mar 2024 | 21.27m | 0.62% |
| China Universal Asset Management Co., Ltd.as of 30 Jun 2023 | 11.51m | 0.34% |
| The Vanguard Group, Inc.as of 31 Mar 2024 | 7.52m | 0.22% |
| Fullgoal Fund Management Co., Ltd.as of 30 Jun 2023 | 7.44m | 0.22% |
| Penghua Fund Management Co., Ltd.as of 30 Jun 2023 | 5.53m | 0.16% |
| China Asset Management Co., Ltd.as of 30 Jun 2023 | 4.54m | 0.13% |
More ▼
Data from 30 Jun 2023 - 29 Apr 2024Source: FactSet Research Systems Inc.
